Terbinafine

CHEMBL822 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
291.4 g/mol
LogP
5.6
Phase
4

This antifungal medication is used to treat fungal infections of the nails and skin, most commonly nail fungus (onychomycosis) and ringworm. It works by interfering with the production of a substance called ergosterol, which is essential for fungal cell membranes. Oral treatment courses can last several weeks to months, and liver function should be monitored.

Moleküler Ağırlık

291,4000 g/mol

LogP

5,60

TPSA

3,20 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12

InChI

InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+

Molecular Formula

C21H25N

HBD / HBA

- / 1

Döndürülebilir Bağlar

5

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This antifungal medication is used to treat fungal infections of the nails and skin, most commonly nail fungus (onychomycosis) and ringworm. It works by interfering with the production of a substance called ergosterol, which is essential for fungal cell membranes. Oral treatment courses can last several weeks to months, and liver function should be monitored.

Yes, Terbinafine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL822. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 1549008. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.